Team (TISI) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
28 Apr, 2026Executive summary
The annual meeting is scheduled for May 20, 2026, with five key proposals up for shareholder vote, including director elections, executive compensation, auditor ratification, a significant warrant issuance, and an equity plan amendment.
Shareholders of record as of April 23, 2026, are eligible to vote, with multiple voting methods available, including online, phone, and mail.
The Board recommends voting in favor of all proposals and emphasizes the importance of shareholder participation.
Voting matters and shareholder proposals
Proposal One: Election of three Class I directors for three-year terms.
Proposal Two: Advisory vote on executive compensation (say-on-pay).
Proposal Three: Ratification of KPMG LLP as independent auditor for 2026.
Proposal Four: Approval of Stellex Warrant Shares Issuance, enabling issuance of shares underlying warrants issued to Stellex.
Proposal Five: Approval of Amendment No. 1 to the 2018 Equity Incentive Plan, increasing shares available for equity awards.
Shareholder proposals for the 2027 meeting must be submitted by December 29, 2026, for proxy inclusion.
Board of directors and corporate governance
The Board consists of eight directors divided into three classes, with a majority being independent under NYSE standards.
Board committees include Audit, Compensation, Corporate Governance and Nominating, and Executive Committees, all chaired by independent directors.
The Board has adopted robust governance policies, including a Code of Business Conduct, Clawback Policy, and ESG Policy.
Leadership structure separates the roles of CEO, Chairman, and Lead Independent Director.
Board diversity and succession planning are emphasized, with active engagement in director evaluations and shareholder communications.
Latest events from Team
- 2026 meeting covers director elections, compensation, auditor, warrant issuance, and equity plan.TISI
Proxy filing24 Mar 2026 - Revenue, operating income, and adjusted EBITDA rose, margins improved, and debt was reduced.TISI
Q4 202513 Mar 2026 - Margins and cash flow improved in Q2 2024, with full-year growth and guidance reaffirmed.TISI
Q2 20242 Feb 2026 - Q3 2024 revenue and margins improved, but guidance was lowered amid ongoing liquidity and NYSE risks.TISI
Q3 202415 Jan 2026 - Margins and EBITDA improved in 2024, with refinancing extending debt maturities to 2030.TISI
Q4 202426 Dec 2025 - Registering 1.45M shares for resale post-$75M private placement, supporting recapitalization.TISI
Registration Filing16 Dec 2025 - Key votes include director elections, auditor ratification, and a charter amendment on director removal.TISI
Proxy Filing2 Dec 2025 - Annual meeting covers director elections, pay, auditor ratification, and governance updates.TISI
Proxy Filing2 Dec 2025 - Flat Q1 revenue, $29.7M net loss, and refinancing set up at least 15% EBITDA growth for 2025.TISI
Q1 202525 Nov 2025